Chief Medical DirectorRichmond Pharmacology, London, United KingdomLondon, England, United Kingdom
PB0228 - A Prospective, Observational Study of Bleeding and Quality of Life in Patients with Glanzmann Thrombasthenia in the United Kingdom: A First Report
Sunday, June 25, 202318:30 – 19:30 ET